Secondary Outcomes
Overall, 49.0% of participants (76 of 157 participants) with GD progressed to A2 GD. The incidence of A2 GD was 48.2% (39 of 83 participants) in the GPNC group and 50.0% (37 of 74 participants) in the IPNC group. The adjusted RD was −6.1% (95% CI, −21.3% to 9.1%) after controlling for all baseline characteristics (